Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

Visualizza tutta la documentazione

Y0000016

Propofol

European Pharmacopoeia (EP) Reference Standard

Sinonimo/i:

2,6-Diisopropylphenol, 2,6-Bis(1-methylethyl)phenol, 2,6-Bis(isopropyl)phenol, Propofol

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula condensata:
[(CH3)2CH]2C6H3OH
Numero CAS:
2078-54-8
Peso molecolare:
178.27
Numero MDL:
MFCD00008885
Codice UNSPSC:
41116107
ID PubChem:
329830815
NACRES:
NA.24

Grado

pharmaceutical primary standard

Tensione di vapore

5.6 mmHg ( 100 °C)

Famiglia di API

propofol

Produttore/marchio commerciale

EDQM

Indice di rifrazione

n20/D 1.514 (lit.)

P. ebollizione

256 °C/764 mmHg (lit.)

Punto di fusione

18 °C (lit.)

Densità

0.962 g/mL at 25 °C (lit.)

applicazioni

pharmaceutical (small molecule)

Formato

neat

Temperatura di conservazione

2-8°C

Stringa SMILE

CC(C)c1cccc(C(C)C)c1O

InChI

1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3
OLBCVFGFOZPWHH-UHFFFAOYSA-N

Informazioni sul gene

human ... GABRA1(2554) , GABRA2(2555) , GABRA3(2556) , GABRA4(2557) , GABRA5(2558) , GABRA6(2559) , GABRB1(2560) , GABRB2(2561) , GABRB3(2562) , GABRD(2563) , GABRE(2564) , GABRG1(2565) , GABRG2(2566) , GABRG3(2567) , GABRP(2568) , GABRQ(55879)

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Propofol EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

Y0000017

Propofol for peak identification, European Pharmacopoeia (EP) Reference Standard

Y0000018

Propofol impurity J, European Pharmacopoeia (EP) Reference Standard

1572503

Propofol, United States Pharmacopeia (USP) Reference Standard

1572547

Propofol Related Compound B, United States Pharmacopeia (USP) Reference Standard

1572525

Propofol Resolution Mixture, United States Pharmacopeia (USP) Reference Standard

1572558

Propofol Related Compound C, United States Pharmacopeia (USP) Reference Standard

1572536

Propofol Related Compound A, United States Pharmacopeia (USP) Reference Standard

BP1031

Propofol, British Pharmacopoeia (BP) Reference Standard

BP698

3,3′-5,5′-Tetraisopropyldiphenol, British Pharmacopoeia (BP) Reference Standard

BP1032

Propofol impurity J, British Pharmacopoeia (BP) Reference Standard

PHR9035

4-Isopropylphenol, reference material

PHR9049

4-Hydroxy-3,5-bis(1-methylethyl)benzoic acid, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

PHR9062

1-(1-Methylethoxy)-2-(1-methylethyl)benzene, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

PHR9074

2,2-Dimethyl-4-(1-methylethyl)-1,3-benzodioxole, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland

PHR2565

Propofol Related Compound A, Pharmaceutical Secondary Standard; Certified Reference Material

PHR2566

Propofol Related Compound B

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302,H315,H319,H335

Classi di pericolo

Acute Tox. 4 Oral - Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Organi bersaglio

Respiratory system

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

235.4 °F - closed cup

Punto d’infiammabilità (°C)

113 °C - closed cup

Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 5

1 of 5

Propofol-D17 solution 100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®

Supelco

P-077

Propofol-D17 solution

Propofol Related Compound C United States Pharmacopeia (USP) Reference Standard

USP

1572558

Propofol Related Compound C

USP

USP

1572547

Propofol Related Compound B

USP

USP

1572536

Propofol Related Compound A

vibrant-m

BP1032

Propofol impurity J

Cynthia Ménard et al.
Radiology, 274(1), 181-191 (2014-09-10)
To determine if the integration of diagnostic magnetic resonance (MR) imaging and MR-guided biopsy would improve target delineation for focal salvage therapy in men with prostate cancer. Between September 2008 and March 2011, 30 men with biochemical failure after radiation
Emily Black et al.
The Annals of pharmacotherapy, 47(6), 856-868 (2013-05-23)
To evaluate the efficacy and safety of propofol compared to other agents for procedural sedation of adults in the emergency department (ED) and to review the use of opioids in conjunction with propofol for procedural sedation in the ED. PubMed
A J Thomson et al.
Anaesthesia, 69(5), 420-428 (2014-04-18)
Debate continues over the most appropriate blood-brain equilibration rate constant (ke0) for use with the Marsh pharmacokinetic model for propofol. We aimed to define the optimal ke0 value. Sixty-four patients were sedated with incremental increases in effect-site target concentration of
Muhammad Suleman Khan et al.
Basic & clinical pharmacology & toxicology, 115(6), 565-570 (2014-06-04)
A variety of techniques have been developed to monitor the depth of anaesthesia. Propofol's pharmacokinetics and response vary greatly, which might be explained by genetic polymorphisms. We investigated the impact of genetic variations on dosage, anaesthetic depth and recovery after
S Bache et al.
British journal of anaesthesia, 110(5), 741-746 (2012-12-22)
Over a 5 yr period, we have encountered three patients in whom remifentanil appeared to have no clinical effect during general anaesthesia (GA). We describe seven anaesthetics in these three patients. We reviewed the literature on this subject. A simple
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.